Clinical trial
A Randomized Clinical Trial to Investigate Safety & Efficacy of Low-dose Aspirin / Ivermectin Combination Therapy in Management of COVID-19 Patients
NCT04768179 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Clinical Trial to Investigate Safety & Efficacy of Low-dose Aspirin / Ivermectin Combination Therapy in Management of COVID-19 Patients
- Lead sponsor
- Makerere University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- February 19, 2021
- Completion date
- September 30, 2021
- Enrollment
- 490 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
covid19